Royal Bank Of Canada Eli Lilly & CO Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Eli Lilly & CO stock. As of the latest transaction made, Royal Bank Of Canada holds 2,554,405 shares of LLY stock, worth $1.92 Billion. This represents 0.48% of its overall portfolio holdings.

Number of Shares

2,554,405

Previous 2,410,160 5.98%

Holding current value

$1.92 Billion

Previous $2.18 Billion 3.71%

% of portfolio

0.48%

Previous 0.52%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $111 Million - $138 Million	144,245 Added 5.98%	2,554,405 $2.26 Billion
Q2 2024 Nov 06, 2024	SELL	$724.87 - $909.04 $25.5 Million - $32 Million	-35,242 Reduced 1.44%	2,410,160 $2.18 Billion
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $57.1 Million - $71.6 Million	78,759 Added 3.33%	2,445,402 $2.21 Billion
Q1 2024 Nov 05, 2024	SELL	$592.2 - $792.28 $66.8 Million - $89.4 Million	-112,835 Reduced 4.61%	2,332,567 $1.81 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $8.99 Million - $12 Million	15,175 Added 0.65%	2,366,643 $1.84 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $69.5 Million - $82 Million	132,425 Added 5.97%	2,351,468 $1.37 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $62.7 Million - $86.5 Million	-144,310 Reduced 6.11%	2,219,043 $1.19 Billion
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $26.2 Million - $35 Million	74,649 Added 3.26%	2,363,353 $1.11 Billion
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $59.1 Million - $69.4 Million	-190,252 Reduced 7.67%	2,288,704 $786 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $39.1 Million - $45.5 Million	121,452 Added 5.15%	2,478,956 $907 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $14.2 Million - $16.2 Million	47,923 Added 2.07%	2,357,504 $762 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $6.92 Million - $8.12 Million	24,818 Added 1.09%	2,309,581 $749 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $34.4 Million - $42.7 Million	-146,497 Reduced 6.03%	2,284,763 $654 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3.85 Million - $4.77 Million	17,106 Added 0.71%	2,431,260 $672 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $8.94 Million - $11 Million	-40,358 Reduced 1.64%	2,414,154 $558 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $443 Million - $573 Million	2,454,512 New	2,454,512 $563 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Eli Lilly & CO Transaction History